CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-01 | Evans John M. CEO | Sale 10b5-1 | −30,663 | $18.35 | $563K | 986,249 |
| 2025-04-01 | Ciaramella Giuseppe President | Sale 10b5-1 | −7,434 | $18.35 | $136K | 190,216 |
| 2025-04-01 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale 10b5-1 | −3,015 | $18.35 | $55K | 44,512 |
| 2025-04-01 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −9,566 | $18.35 | $176K | 86,739 |
| 2025-03-31 | Bellon Christine Chief Legal Officer | Grant or award | +20,000 | 122,968 | ||
| 2025-03-31 | Simon Amy Chief Medical Officer | Grant or award | +27,500 | 96,305 | ||
| 2025-03-31 | Ciaramella Giuseppe President | Grant or award | +35,000 | 197,650 | ||
| 2025-03-31 | Cavanagh Bethany J SVP, Finance and Treasurer | Grant or award | +10,000 | 47,527 | ||
| 2025-03-31 | Evans John M. CEO | Grant or award | +77,500 | 1,016,159 | ||
| 2025-02-18 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale 10b5-1 | −6,287 | $35.00 | $220K | 37,527 |
| 2025-02-14 | Bellon Christine Chief Legal Officer | Option exercise 10b5-1 | +9,492 | $7.22 | $69K | 112,460 |
| 2025-02-14 | Bellon Christine Chief Legal Officer | Option exercise 10b5-1 | +508 | $7.22 | $4K | 112,968 |
| 2025-02-14 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −10,000 | $34.00 | $340K | 102,968 |
| 2025-02-14 | Bellon Christine Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,492 | 0 | ||
| 2025-02-14 | Bellon Christine Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −508 | 10,410 | ||
| 2025-01-31 | Bellon Christine Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-01-31 | Ciaramella Giuseppe President | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2025-01-31 | Simon Amy Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-01-31 | Evans John M. CEO | Grant or award · Stock Option (Right to Buy) 10b5-1 | +155,000 | 155,000 | ||
| 2025-01-31 | Cavanagh Bethany J SVP, Finance and Treasurer | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 6 of 32 · 630 trades